A redraw of a very old oc, from the baby days! Prev versions below the cut!
seen from China
seen from Italy
seen from Norway
seen from China

seen from Türkiye

seen from Türkiye
seen from United States

seen from United States
seen from Türkiye
seen from Malaysia
seen from United States
seen from Yemen

seen from Philippines

seen from United States

seen from United States

seen from Türkiye
seen from Netherlands
seen from Spain

seen from United States
seen from China
A redraw of a very old oc, from the baby days! Prev versions below the cut!
Factor V Leiden
-- mutation of one of the clotting factors, called factor V
-- mutation increases chances of developing abnormal blood clots
-- these developments are called thrombophilia
-- most people with the mutation never develop abnormal clots
-- both men and women can have the mutation
-- women have an increased tendency to develop blood clots during pregnancy or when taking estrogen
-- anticoagulant medications can lessen the risk of developing additional blood clots
Patreon | Ko-fi
I'm the Anon with the clotting disorder that asked about pellets, I have factor 5 Leiden thrombosis, which causes an increase in clotting factors. I was told by my doctor I couldn't take pills/injections of either sex hormones but she has limited knowledge of transitional medicine and I don't know for sure that she even knows about pellets to begin with
according to current recommendations based on the research we have, People with factor V Leiden should be urged not to have HRT (testosterone or estrogen) in any form (that would include pellets, shots, oral, gel- because they would all have the same risk of clotting once they reach any level in your body to cause changes). Mod mayhem
Graag tekenen zodat de coronapas onzin niet doorgaat https://factor-v.be/nl/open-letters/wat-nu. Morgen is het te laat, want dan worden de handtekeningen aangeboden. Hartelijk dank! Vergeef iedereen, want ze weten niet wat ze doen. Goed werk Luc! #wewillallbethere Luc De Wandel: "De open brief van onze stichting ‘Factor V’ wordt door de pers gretig opgepikt. En terecht: alle punten die er in worden aangehaald (zie mijn vorige post en zie hier https://factor-v.be/nl/open-letters/wat-nu ) zijn maatschappelijk belangwekkend genoeg om een diepgaand en fundamenteel debat te rechtvaardigen. Allicht zal de Open Brief, die niet alleen door tientallen wetenschappers werd ondertekend, maar inmiddels ook door bijna 6500 andere bezorgde burgers, dan ook morgen op het overlegcomité van de overheid op de agenda staan. De grote namen uit de wetenschappelijke wereld, die de oproep mee ondertekend hebben, vallen nu eenmaal moeilijk te negeren. Hopelijk hebben die overheden dan ook oor voor de constructieve voorstellen van Factor V en COVID Rationnel, die moeten toelaten om zo snel mogelijk uit de huidige impasse te geraken.De bal is aan het rollen. U kunt die bal ook nog een duwtje geven door de brief mee te ondertekenen, via de link hierboven. Doen!"
The National Blood Clot Alliance (NBCA) is a non-profit, voluntary health organization dedicated to advancing the prevention, early diagnosis and successful treatment of life-threatening blood clots such as deep vein thrombosis, pulmonary embolism, and clot-provoked stroke.
FVL Resource: Stoptheclot.org
Understanding FVL from the NCBI
Summary:
Factor V Leiden thrombophilia is an inherited disorder of blood clotting. Factor V Leiden is the name of a specific gene mutation that results in thrombophilia, which is an increased tendency to form abnormal blood clots that can block blood vessels. People with factor V Leiden thrombophilia have a higher than average risk of developing a type of blood clot called a deep venous thrombosis (DVT). DVTs occur most often in the legs, although they can also occur in other parts of the body, including the brain, eyes, liver, and kidneys. Factor V Leiden thrombophilia also increases the risk that clots will break away from their original site and travel through the bloodstream. These clots can lodge in the lungs, where they are known as pulmonary emboli. Although factor V Leiden thrombophilia increases the risk of blood clots, only about 10 percent of individuals with the factor V Leiden mutation ever develop abnormal clots. The factor V Leiden mutation is associated with a slightly increased risk of pregnancy loss (miscarriage). Women with this mutation are two to three times more likely to have multiple (recurrent) miscarriages or a pregnancy loss during the second or third trimester. Some research suggests that the factor V Leiden mutation may also increase the risk of other complications during pregnancy, including pregnancy-induced high blood pressure (preeclampsia), slow fetal growth, and early separation of the placenta from the uterine wall (placental abruption). However, the association between the factor V Leiden mutation and these complications has not been confirmed. Most women with factor V Leiden thrombophilia have normal pregnancies. [from GHR]
Source: NCBI
#Themoreyouknow
Understanding FVL
Read the NY Times article here: http://www.nytimes.com/2008/06/10/health/10brody-.html?_r=0